Avalyn Pharma Inc. Common Stock (AVLN)
Stock · NASDAQ · Health Care
$34.69as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$27.92
Industry
Biotechnology: Pharmaceutical Preparations
About AVLN
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfeni…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 55
- Website
- www.avalynpharma.com
Fundamentals
- 1-day range
- $35.07$39.48
- Market cap
- $1.26B
- P/E (trailing)
- —
- P/E (forward)
- -20.66
- EPS (trailing)
- $-2.33
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 334.5K
52-week range
$24.15$39.99
Forecasts
4 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$80
+130.6%
Median
$54.5
+57.1%
Low
$51
+47.0%
Avalyn Pharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AVLNAvalyn Pharma Inc. Common Stock$34.67▼ 5.04%Market cap $1.26BP/E —$24.15$39.99
- ETONEton Pharmaceuticals Inc. Common Stock$59.79▼ 4.60%Market cap $1.24BP/E 150.92$14.27$66.37
- ARDXArdelyx Inc. Common Stock$3.81▼ 0.26%Market cap $1.23BP/E —$3.73$8.4
- LBRXLB Pharmaceuticals Inc Common Stock$47.8▼ 0.20%Market cap $1.23BP/E —$13.36$50.16
- MNKDMannKind Corporation Common Stock$3.96▼ 2.59%Market cap $1.21BP/E —$2.23$6.51
- AVBPArriVent BioPharma Inc. Common Stock$30.19▼ 2.63%Market cap $1.38BP/E —$17$35.83
- SDGRSchrodinger Inc. Common Stock$19.7▼ 3.48%Market cap $1.14BP/E —$10.95$23.02
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AVLN Avalyn Pharma Inc. Common Stock | $1.26B | — | $34.67 | ▼ 5.04% | $24.15$39.99 |
| ETON Eton Pharmaceuticals Inc. Common Stock | $1.24B | 150.92 | $59.79 | ▼ 4.60% | $14.27$66.37 |
| ARDX Ardelyx Inc. Common Stock | $1.23B | — | $3.81 | ▼ 0.26% | $3.73$8.4 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.23B | — | $47.8 | ▼ 0.20% | $13.36$50.16 |
| MNKD MannKind Corporation Common Stock | $1.21B | — | $3.96 | ▼ 2.59% | $2.23$6.51 |
| AVBP ArriVent BioPharma Inc. Common Stock | $1.38B | — | $30.19 | ▼ 2.63% | $17$35.83 |
| SDGR Schrodinger Inc. Common Stock | $1.14B | — | $19.7 | ▼ 3.48% | $10.95$23.02 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Morgan Stanley Maintains Overweight on Avalyn Pharma, Raises Price Target to $57Benzinga · 8/13/2026
- Avalyn Pharma Q2 EPS $(0.65) Misses $(0.53) EstimateBenzinga · 8/12/2026
Insider Activity
Insider Actions →Acquired
6.45M
Disposed
100.76M
- FMR LLC · May 1, 2026 · Conversion377.9K
- FMR LLC · May 1, 2026 · Conversion225.8K
- FMR LLC · May 1, 2026 · Conversion872.9K
- FMR LLC · May 1, 2026 · Conversion80.3K
- FMR LLC · May 1, 2026 · Conversion727.6K
- Novo Holdings A/S · May 1, 2026 · Conversion12.56M
- Novo Holdings A/S · May 1, 2026 · Conversion5.59M
- Novo Holdings A/S · May 1, 2026 · Conversion25.90M
- Novo Holdings A/S · May 1, 2026 · Conversion1.99M
- Novo Holdings A/S · May 1, 2026 · Conversion18.00M
- Novo Holdings A/S · May 1, 2026 · Buy555.6K @ $18
- Novo Holdings A/S · May 1, 2026 · Conversion3.33M
- Jill Carroll · May 1, 2026 · Conversion9.42M
- Jill Carroll · May 1, 2026 · Conversion27.31M
- Jill Carroll · May 1, 2026 · Buy277.8K @ $18
See the full, filterable feed with live charts on the MarketWall dashboard.